Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Abraxis Bioscience (MM) (ABBI)

Abraxis Bioscience (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABBI
DateTimeSourceHeadlineSymbolCompany
12/11/200814:00PR Newswire (US)Deloitte Names Abraxis BioScience Inc. Fastest Growing Technology Company in Los Angeles AreaNASDAQ:ABBIAbraxis Bioscience (MM)
12/11/200813:00PR Newswire (US)Deloitte Unveils 2008 Technology Fast 500 RankingNASDAQ:ABBIAbraxis Bioscience (MM)
13/11/200722:02Edgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (S-8 POS)NASDAQ:ABBIAbraxis Bioscience (MM)
13/11/200722:01Edgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (S-8 POS)NASDAQ:ABBIAbraxis Bioscience (MM)
13/11/200722:00Edgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (S-8 POS)NASDAQ:ABBIAbraxis Bioscience (MM)
13/11/200721:55Edgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (S-8 POS)NASDAQ:ABBIAbraxis Bioscience (MM)
13/11/200721:55Edgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (POSASR)NASDAQ:ABBIAbraxis Bioscience (MM)
13/11/200716:19Edgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (8-K)NASDAQ:ABBIAbraxis Bioscience (MM)
08/11/200716:03Edgar (US Regulatory)Abraxis Bioscience, Inc. - Current report filing (8-K)NASDAQ:ABBIAbraxis Bioscience (MM)
05/11/200721:58Edgar (US Regulatory)Abraxis Bioscience, Inc. - Prospectus filed pursuant to Rule 424(b)(7) (424B7)NASDAQ:ABBIAbraxis Bioscience (MM)
30/10/200720:23Edgar (US Regulatory)Abraxis Bioscience, Inc. - Statement of Changes in Beneficial Ownership (4)NASDAQ:ABBIAbraxis Bioscience (MM)
30/10/200720:23Edgar (US Regulatory)Abraxis Bioscience, Inc. - Statement of Changes in Beneficial Ownership (4)NASDAQ:ABBIAbraxis Bioscience (MM)
30/10/200720:22Edgar (US Regulatory)Abraxis Bioscience, Inc. - Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:ABBIAbraxis Bioscience (MM)
30/10/200720:22Edgar (US Regulatory)Abraxis Bioscience, Inc. - Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:ABBIAbraxis Bioscience (MM)
10/08/200713:05Business WireAPP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for InjectionNASDAQ:ABBIAbraxis Bioscience (MM)
10/08/200701:50Business WireAbraxis BioScience Files Information Statement in Connection with Its Announced Separation into Two Publicly Traded CompaniesNASDAQ:ABBIAbraxis Bioscience (MM)
09/08/200713:05Business WireAbraxis BioScience Reports Second Quarter 2007 Revenue of $243 Million versus $161 Million in Prior Year PeriodNASDAQ:ABBIAbraxis Bioscience (MM)
09/08/200703:35Business WireAbraxis BioScience Announces Licensing Agreement with Biocon Limited for the Commercialization of ABRAXANE in IndiaNASDAQ:ABBIAbraxis Bioscience (MM)
08/08/200723:20Business WireAbraxis BioScience Launches Doxorubicin Hydrochloride Injection, USPNASDAQ:ABBIAbraxis Bioscience (MM)
07/08/200713:00Business WireAbraxis BioScience Receives FDA Approval for Oxytocin Injection 10 USP Units/mL in a 30 mL VialNASDAQ:ABBIAbraxis Bioscience (MM)
06/08/200721:15Business WireAbraxis BioScience Receives Final Approval for Fosphenytoin Sodium Injection, USPNASDAQ:ABBIAbraxis Bioscience (MM)
06/08/200713:00Business WireAbraxis BioScience Acquires from the Buck Institute Exclusive Worldwide Intellectual Property Rights for Technologies Designed tNASDAQ:ABBIAbraxis Bioscience (MM)
02/08/200723:55Business WireAbraxis BioScience Receives FDA Approval for Caffeine Citrate Injection USP, 20 mg/mLNASDAQ:ABBIAbraxis Bioscience (MM)
31/07/200721:45Business WireAbraxis BioScience Acquires Manufacturing Facility from WatsonNASDAQ:ABBIAbraxis Bioscience (MM)
26/07/200713:00Business WireAbraxis BioScience and the California NanoSystems Institute Announce Partnership for Collaborative Research in the Development oNASDAQ:ABBIAbraxis Bioscience (MM)
19/07/200721:05Business WireAbraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European UnionNASDAQ:ABBIAbraxis Bioscience (MM)
16/07/200721:05Business WireAbraxis BioScience Announces Date for Second Quarter Financial Results and Investor Conference CallNASDAQ:ABBIAbraxis Bioscience (MM)
02/07/200712:05Business WireAbraxis BioScience Announces Plan to Separate Into Two Independent Public CompaniesNASDAQ:ABBIAbraxis Bioscience (MM)
19/06/200713:00Business WireAbraxis BioScience Exclusively Licenses Intellectual Property Portfolio Designed to Personalize Treatment for Colorectal CancerNASDAQ:ABBIAbraxis Bioscience (MM)
07/06/200713:00Business WireAbraxis BioScience to Present at the Goldman Sachs 28th Annual Global Healthcare ConferenceNASDAQ:ABBIAbraxis Bioscience (MM)
 Showing the most relevant articles for your search:NASDAQ:ABBI

Your Recent History

Delayed Upgrade Clock